Myocardial protection with Perhexiline in Left Ventricular Hypertrophy - Perhexiline in LVH
Phase 1
- Conditions
- Patients with left ventricular hypertrophy undergoing aortic valve surgery (with or without coronary artery surgery)
- Registration Number
- EUCTR2008-002376-95-GB
- Lead Sponsor
- niversity Hospital Birmingham NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
Adult patients with left ventricular hypertrophy undergoing first-time aortic valve replacement surgery with or without coronary artery bypass surgery.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Diabetes mellitus, renal impairment (serum creatinine> 200µmol/L), pregnancy, procedures involving other heart valves and surgery for catastrophic event.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method